PCRBF(PCRBF)
PCRBF
No analyst ratings available
No analyst price targets available for PCRBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.06B | $2.14B | $2.25B |
| Low | $2.06B | $2.14B | $2.25B |
| High | $2.06B | $2.14B | $2.25B |
| EBITDA Avg | $131M | $137M | $143M |
| Low | $131M | $137M | $143M |
| High | $131M | $137M | $143M |
| EBIT Avg | $70M | $73M | $77M |
| Low | $70M | $73M | $77M |
| High | $70M | $73M | $77M |
| Net Income Avg | $67M | $58M | $70M |
| Low | $67M | $58M | $70M |
| High | $67M | $58M | $70M |
| EPS Avg | $0.41 | $0.36 | $0.43 |
| Low | $0.41 | $0.36 | $0.43 |
| High | $0.41 | $0.36 | $0.43 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $586M | $592M | $455M |
| Low | $586M | $592M | $455M |
| High | $586M | $592M | $455M |
| EBITDA Avg | $37M | $38M | $29M |
| Low | $37M | $38M | $29M |
| High | $37M | $38M | $29M |
| EBIT Avg | $20M | $20M | $16M |
| Low | $20M | $20M | $16M |
| High | $20M | $20M | $16M |
| Net Income Avg | $27M | $18M | $-7M |
| Low | $27M | $18M | $-7M |
| High | $27M | $18M | $-7M |
| EPS Avg | $0.16 | $0.11 | $-0.04 |
| Low | $0.16 | $0.11 | $-0.04 |
| High | $0.16 | $0.11 | $-0.04 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |